HK1164369A1 - Preparation of microvesicle-sirna composition and use of the same in aids treatment - Google Patents

Preparation of microvesicle-sirna composition and use of the same in aids treatment

Info

Publication number
HK1164369A1
HK1164369A1 HK12105108.4A HK12105108A HK1164369A1 HK 1164369 A1 HK1164369 A1 HK 1164369A1 HK 12105108 A HK12105108 A HK 12105108A HK 1164369 A1 HK1164369 A1 HK 1164369A1
Authority
HK
Hong Kong
Prior art keywords
microvesicle
preparation
same
aids treatment
sirna composition
Prior art date
Application number
HK12105108.4A
Original Assignee
Micromedmark Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micromedmark Biotech Co Ltd filed Critical Micromedmark Biotech Co Ltd
Publication of HK1164369A1 publication Critical patent/HK1164369A1/en

Links

HK12105108.4A 2010-05-26 2012-05-24 Preparation of microvesicle-sirna composition and use of the same in aids treatment HK1164369A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010187578A CN101869715A (en) 2010-05-26 2010-05-26 Cell particles carrying interfering ribonucleic acid (RNA), preparation method and application thereof

Publications (1)

Publication Number Publication Date
HK1164369A1 true HK1164369A1 (en) 2012-09-21

Family

ID=42994919

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105108.4A HK1164369A1 (en) 2010-05-26 2012-05-24 Preparation of microvesicle-sirna composition and use of the same in aids treatment

Country Status (2)

Country Link
CN (2) CN101869715A (en)
HK (1) HK1164369A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9421167B2 (en) 2010-05-26 2016-08-23 Micromedmark Biotech Co. Ltd. Preparation of microvesicle-siRNA complexes and use thereof in AIDS treatment
WO2011147086A1 (en) 2010-05-26 2011-12-01 江苏命码生物科技有限公司 Microvesicles carrying small interfering rnas, preparation methods and uses thereof
CN103757001B (en) * 2010-12-09 2016-03-16 江苏命码生物科技有限公司 The preparation of cell particles-siRNA mixture and the application in treating AIDS thereof
CN103505743A (en) * 2012-06-21 2014-01-15 北京命码生科科技有限公司 Cell micro-particles containing functional microRNA/siRNA and application thereof
CN105051192B (en) 2012-11-13 2020-04-17 科迪艾克生物科学公司 Delivery of therapeutic agents
EP2975125B1 (en) * 2013-03-13 2020-04-29 Li, Zhong Microvesicle, and manufacturing method for same
CA2909442A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
CN103212090A (en) * 2013-04-18 2013-07-24 南京大学 Application of microvesicle containing TGF (transforming growth factor)-beta1 siRNA (small interfering Ribonucleic Acid)
CN106177990B (en) * 2014-11-17 2020-08-28 江苏命码生物科技有限公司 New precursor miRNA and application thereof in tumor treatment
AU2016275046B2 (en) 2015-06-10 2022-07-28 Board Of Regents, The University Of Texas System Use of exosomes for the treatment of disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101354995B1 (en) * 2005-09-08 2014-01-23 사이단호진한다이비세이부쯔뵤우겐큐우카이 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof
CN101432432A (en) * 2006-05-03 2009-05-13 扬·奥洛夫·洛特温尔 Exosome transfer of nucleic acids to cells
US20110177054A1 (en) * 2008-06-06 2011-07-21 Derrick Gibbings Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna

Also Published As

Publication number Publication date
CN102260667A (en) 2011-11-30
CN102260667B (en) 2014-01-15
CN101869715A (en) 2010-10-27

Similar Documents

Publication Publication Date Title
EP2611413A4 (en) Skin compositions and methods of use thereof
HK1164369A1 (en) Preparation of microvesicle-sirna composition and use of the same in aids treatment
EP2432462A4 (en) Endoxifen methods and compositions in the treatment of mammalian diseases
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
ZA201205683B (en) Probiotic composition for use in the treatment of bowel inflammation
IL223241A0 (en) Cysteamine derivatives and their use in the treatment of nash
PL2627334T3 (en) Compositions for use in the treatment of viral infections
EP2536756A4 (en) Hsa-related compositions and methods of use
EP2584897A4 (en) Resveratrol-containing compositions and methods of use
IL216582A0 (en) Composition for use in decreasing the transmission of human pathogens, devices comprising the same and uses thereof
HK1180320A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
PL2771041T3 (en) Compositions and their use in bone healing
EP2448581A4 (en) Therapeutic compositions and related methods of use
ZA201300612B (en) Novel bacteria and methods of use thereof
HK1180322A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
EP2528603A4 (en) Pharmaceutical compositions for the treatment of pain and other indicatons
EP2596112A4 (en) Acetycysteine compositions and methods of use thereof
EP2563372A4 (en) Prebiotic formulations and methods of use
HK1185552A1 (en) Use of interleukin-22 in treating viral hepatitis -22
PT2521445T (en) Formulation and use thereof
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
HK1193379A1 (en) Remedial composition and treatment methods
PT2563806E (en) Human leukolectins and uses thereof
IL233875A (en) Composition and use thereof in the treatment of anal rhagades
PT2590509T (en) Method for the preparation and the use of biocides enriched in active radicals before usage

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191207